1. Home
  2. HOWL vs BRFH Comparison

HOWL vs BRFH Comparison

Compare HOWL & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • BRFH
  • Stock Information
  • Founded
  • HOWL 2017
  • BRFH 2005
  • Country
  • HOWL United States
  • BRFH United States
  • Employees
  • HOWL N/A
  • BRFH N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • BRFH Packaged Foods
  • Sector
  • HOWL Health Care
  • BRFH Consumer Staples
  • Exchange
  • HOWL Nasdaq
  • BRFH Nasdaq
  • Market Cap
  • HOWL 62.4M
  • BRFH 50.9M
  • IPO Year
  • HOWL 2021
  • BRFH N/A
  • Fundamental
  • Price
  • HOWL $1.23
  • BRFH $3.46
  • Analyst Decision
  • HOWL Strong Buy
  • BRFH Strong Buy
  • Analyst Count
  • HOWL 3
  • BRFH 1
  • Target Price
  • HOWL $9.00
  • BRFH $4.50
  • AVG Volume (30 Days)
  • HOWL 241.7K
  • BRFH 14.9K
  • Earning Date
  • HOWL 03-11-2025
  • BRFH 03-27-2025
  • Dividend Yield
  • HOWL N/A
  • BRFH N/A
  • EPS Growth
  • HOWL N/A
  • BRFH N/A
  • EPS
  • HOWL N/A
  • BRFH N/A
  • Revenue
  • HOWL $1,885,000.00
  • BRFH $9,851,000.00
  • Revenue This Year
  • HOWL $36.45
  • BRFH $51.72
  • Revenue Next Year
  • HOWL $296.58
  • BRFH $38.85
  • P/E Ratio
  • HOWL N/A
  • BRFH N/A
  • Revenue Growth
  • HOWL N/A
  • BRFH 29.01
  • 52 Week Low
  • HOWL $1.03
  • BRFH $1.02
  • 52 Week High
  • HOWL $6.89
  • BRFH $4.61
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 44.53
  • BRFH 45.94
  • Support Level
  • HOWL $1.18
  • BRFH $3.35
  • Resistance Level
  • HOWL $1.29
  • BRFH $3.90
  • Average True Range (ATR)
  • HOWL 0.10
  • BRFH 0.29
  • MACD
  • HOWL 0.00
  • BRFH -0.08
  • Stochastic Oscillator
  • HOWL 56.10
  • BRFH 19.26

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: